AN2 Therapeutics News

12 Health Care Stocks Moving In Friday's After-Market Session

GainersKineta (NASDAQ:KA) shares moved upwards by 28.5% to $0.67 during Friday's after-market session. The company's market cap stands at $8.1 million. iSpecimen (NASDAQ:ISPC) stock moved upwards by 1

BenzingaJun 14 16:31 ET

Maintain Market Perform: Balancing Potential and Uncertainty in AN2 Therapeutics' Drug Development

TipRanksMay 20 02:15 ET

AN2 Therapeutics Is Maintained at In-Line by Evercore ISI Group

AN2 Therapeutics Is Maintained at In-Line by Evercore ISI Group

Dow JonesMay 16 12:02 ET

Express News | Evercore ISI Group Maintains In-Line on AN2 Therapeutics, Lowers Price Target to $2

BenzingaMay 16 11:51 ET

Express News | AN2 Therapeutics Inc : Evercore ISI Cuts Target Price to $2 From $7

ReutersMay 16 00:53 ET

Analysts Are Bullish on These Healthcare Stocks: AN2 Therapeutics, Inc. (ANTX), Heron Therapeutics (HRTX)

TipRanksMay 15 16:40 ET

TD Cowen Remains a Buy on AN2 Therapeutics, Inc. (ANTX)

TipRanksMay 15 14:55 ET

Oppenheimer Sticks to Their Hold Rating for AN2 Therapeutics, Inc. (ANTX)

TipRanksMay 15 07:46 ET

AN2 Therapeutics | 10-Q: Quarterly report

SEC announcementMay 14 16:19 ET · Announcements

AN2 Therapeutics | 10-K/A: Annual report (Amendment)

SEC announcementMay 14 16:06 ET · Announcements

Express News | AN2 Therapeutics Inc: Cash, Cash Equivalents, and Investments of $118.1 Mln at March 31, 2024

ReutersMay 14 16:05 ET

Express News | AN2 Therapeutics Q1 EPS USD -0.56

ReutersMay 14 16:01 ET

Express News | AN2 Therapeutics Q1 Income From Operations USD -18.296 Million

ReutersMay 14 16:01 ET

Express News | AN2 Therapeutics Q1 Net Income USD -16.617 Million

ReutersMay 14 16:01 ET

Express News | AN2 Therapeutics Q1 Operating Expenses USD 18.296 Million

ReutersMay 14 16:01 ET

Express News | AN2 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business and Scientific Highlights

ReutersMay 14 16:01 ET

OPI, RVNC and AQST Are Among After Hour Movers

Seeking AlphaApr 22 16:53 ET

Maintaining Caution: AN2 Therapeutics Hold Rating Amidst Epetraborole Trial Uncertainties

TipRanksApr 8 03:55 ET

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersOrgenesis (NASDAQ:ORGS) shares increased by 8.5% to $0.63 during Thursday's after-market session. The company's market cap stands at $21.4 million. AN2 Therapeutics (NASDAQ:ANTX) shares increas

BenzingaApr 4 16:31 ET

AN2 Therapeutics Price Target Announced at $6.00/Share by JMP Securities

AN2 Therapeutics Price Target Announced at $6.00/Share by JMP Securities

Dow JonesApr 2 14:16 ET